Stevanato Group S.p.A (STVN) Cash from Operations (2020 - 2026)
Stevanato Group S.p.A's (STVN) quarterly Cash from Operations came in at 88377247.63 in Q1 2026, down 15.81% year-on-year from 104978067.07 in Q1 2025, and down 19.32% on a QoQ basis from 109536494.73 in Q4 2025.
Stevanato Group S.p.A (STVN) Cash from Operations (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has 7 years of Cash from Operations data on file, last reported at 88377247.63 in Q1 2026.
- On a quarterly basis, Cash from Operations fell 15.81% year-over-year to 88377247.63 in Q1 2026; TTM through Mar 2026 was 303918132.67, a 55.31% increase from a year earlier, with the FY2025 full-year figure at 333032849.56, up 100.04% from the prior year.
- Cash from Operations for Q1 2026 stood at 88377247.63, down from 109536494.73 in the prior quarter.
- Over the last five years, Cash from Operations for STVN reached as high as 109536494.73 in Q4 2025 and fell as low as 3831442.45 in Q3 2022.
- Historically, Cash from Operations has averaged 47006043.12 across 5 years, with a median of 45029792.24 in 2022.
- Across the five-year window, Cash from Operations sank 118.15% in 2022 and soared 1051.8% in 2023, its largest moves.
- Year by year, Cash from Operations stood at 60908767.71 in 2022, then sank by 81.98% to 10974587.07 in 2023, then surged by 324.53% to 46590759.45 in 2024, then surged by 135.1% to 109536494.73 in 2025, then retreated by 19.32% to 88377247.63 in 2026.
- Per Business Quant data, the three most recent Cash from Operations figures were 88377247.63 in Q1 2026, 109536494.73 in Q4 2025, and 55179400.31 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 418.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 1.06 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 671.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 412.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 554.13 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 124.00 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 182.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -189.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 151.04 Mn |
| 10 | Stevanato Group S.p.A | 5.29 Bn | 5.15 Bn | 88.01 Mn | 88.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 88.38 Mn |
| Mar 31, 2026 | 88.38 Mn |
| Dec 31, 2025 | 109.54 Mn |
| Dec 31, 2025 | 109.54 Mn |
| Sep 30, 2025 | 55.18 Mn |
| Sep 30, 2025 | 55.18 Mn |
| Jun 30, 2025 | 50.82 Mn |
| Jun 30, 2025 | 50.82 Mn |
| Mar 31, 2025 | 104.98 Mn |
| Mar 31, 2025 | 104.98 Mn |
| Dec 31, 2024 | 46.59 Mn |
| Dec 31, 2024 | 46.59 Mn |
| Sep 30, 2024 | 20.10 Mn |
| Sep 30, 2024 | 20.10 Mn |
| Jun 30, 2024 | 24.01 Mn |
| Jun 30, 2024 | 24.01 Mn |
| Mar 31, 2024 | 77.78 Mn |
| Mar 31, 2024 | 77.78 Mn |
| Dec 31, 2023 | 10.97 Mn |
| Dec 31, 2023 | 10.97 Mn |